Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,242 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07398417RecruitingPhase 3
Testing esreboxetine for fibromyalgia relief
This study tests a medicine called esreboxetine to see if it helps people with fibromyalgia. First, everyone gets the medicine, then some may switch to a placebo to see if the medicine keeps working better than no treatment.
Glendale, ArizonaAges 18 years+ - NCT07400003RecruitingPhase 1/Phase 2
Shingles mRNA vaccine safety and immune response study
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
XinjiangAges 40 years+ - NCT07400965RecruitingPhase 2
Testing a new eye drop for eyelid inflammation caused by tiny mites
This trial tests an investigational eye drop (GLK-321) to see if it safely and effectively treats Demodex blepharitis, an eyelid inflammation caused by tiny mites. It may help people who have signs of this condition and good enough vision.
Newport Beach, CaliforniaAges 18 years+ - NCT07402941Recruiting
Testing inner ear stimulation during awake ear surgery
This study tests a new way to stimulate your hearing nerve during ear surgery while you are awake. It might help doctors better understand hearing loss and improve future treatments.
Cleveland, OhioAges 18 years+ - NCT07400952RecruitingPhase 2
Testing GLK-221 Eye Drops for Keratoconus
This study tests an eye drop called GLK-221 for people with keratoconus, a condition where the clear front of the eye bulges. The goal is to see if the drops can safely help improve the condition compared to a placebo (an inactive solution).
Westerville, OhioAges 18–55 - NCT07399171RecruitingPhase 2
Testing HT-4253 to prevent Alzheimer's in APOE4 carriers
This trial tests an experimental drug called HT-4253 to see if it can prevent Alzheimer's disease in people who are at higher genetic risk (carry the APOE4 gene) and have early signs of amyloid buildup in the brain. If you qualify, you would take the drug or a placebo and be monitored over time.
Abu Dhabi, Abu Dhabi EmirateAges 50–75 - NCT07402239Recruiting
Heart failure therapy and monitoring device study
This trial tests a device that treats and monitors heart failure. It may help people with chronic heart failure and reduced heart function who still have symptoms despite standard treatments.
Fuzhou, FujianAges 18 years+ - NCT07404033RecruitingPhase 1
Testing a lotion for mild to moderate dandruff rash
This trial tests a new lotion for people with mild to moderate seborrheic dermatitis (a common skin condition causing red, scaly patches on the scalp, face, or chest). The study checks safety and how well the lotion works.
Suzhou, JiangsuAges 18–65 - NCT07407062Recruiting
Study of folate receptor alpha in ovarian cancer tissue
This study looks at a marker called folate receptor alpha in tissue samples from people with ovarian, fallopian tube, or primary peritoneal cancer that has returned. The goal is to see how common this marker is, which may help guide future treatment options.
Rome, RomaAges 18 years+ - NCT07399665Recruiting
Tezepelumab for chronic sinusitis with nasal polyps in Russia
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
Kazan'Ages 18 years+ - NCT07403552RecruitingPhase 1
Testing a new drug's safety in healthy volunteers
This trial is testing a new drug called NSHO-101 in healthy people to see how the body processes it and if it is safe. It helps researchers learn about the drug before testing it in patients with a condition.
Anaheim, CaliforniaAges 18 years+ - NCT07405801RecruitingPhase 2
Inavolisib plus ribociclib plus fulvestrant for advanced breast cancer
This trial tests a combination of three drugs (inavolisib, ribociclib, and fulvestrant) compared to a placebo plus two of the drugs (ribociclib and fulvestrant) for people with advanced hormone receptor-positive breast cancer who have not had prior treatment for advanced disease. The goal is to see if adding inavolisib improves outcomes.
Anaheim, CaliforniaAges 18 years+ - NCT05724745Recruiting
3D lung breathing test during MRI versus standard spirometry
This study compares a new 3D MRI-based breathing test with the usual breathing test called spirometry. It may help doctors measure lung function more precisely in healthy people and in people with asthma, COPD, or after a double lung transplant.
Orsay, FranceAges 18–90 - NCT07400835Recruiting
Using DNA markers to find endometrial cancer in postmenopausal bleeding
This trial tests whether DNA changes in urine, vaginal, or cervical samples can help find endometrial cancer earlier in women with postmenopausal bleeding. If you are having tests for this bleeding, your samples could help improve detection.
Aarhus NAges Any age - NCT07398950Enrolling by invitation
AI screening for a heart condition called ATTR-CM
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
New Haven, ConnecticutAges 18 years+ - NCT07405931Recruiting
Managing chemo side effects with phone calls and a smartphone app
This study tests whether checking in by phone or smartphone app can help manage chemotherapy side effects. If you are starting a new chemo for stomach, lung, breast, or colon cancer, this program may support you from home.
BusanAges 19 years+ - NCT07400848Recruiting
Symptoms and recovery after COVID-19 vaccine
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
BernAges 18 years+ - NCT07398222Recruiting
Stomach contents in tirzepatide users and fasting volunteers
This study uses an ultrasound to look at the stomach contents of people who are taking tirzepatide compared to those who are not. It will help doctors understand how this medication affects stomach emptying during fasting.
São Paulo, São PauloAges 18 years+ - NCT07402057Recruiting
Talking about palliative care: a study to improve conversations
This study tests a program to help doctors and patients have better conversations about palliative care. It is for adults with advanced cancer that cannot be cured, their doctors, and hospital staff who might help start these talks.
Aalst, East-FlandersAges 18 years+ - NCT07402681Recruiting
Tracking change in teens after trauma with weekly therapy
This study tests a type of talk therapy (TF-CBT) for teens who have been through trauma and still have upsetting symptoms like nightmares, flashbacks, or strong anxiety. It focuses on tracking how symptoms change over time and offers weekly sessions with a supportive adult.
Zurich, Canton of ZurichAges 12–18 - NCT07399093Recruiting
Ultrasound test before brain surgery anesthesia
This trial uses ultrasound to measure blood flow and fluid levels in the body before brain surgery. It aims to help doctors manage fluids better during and after anesthesia.
CairoAges 18–40 - NCT07405905Recruiting
Comparing mini implant placements for fixing upper teeth overbite
This study tests two ways of placing small temporary anchors (mini implants) in the jaw to help pull upper front teeth back into a better position. It is for patients who have finished growing and have a Class II overbite, to see which anchor location works best.
Rohtak, HaryanaAges 18–30 - NCT07400510Enrolling by invitation
Ultrasound for DVT diagnosis and treatment
This trial uses a bedside ultrasound to quickly diagnose deep vein thrombosis (DVT) and help guide treatment. It may help patients who have symptoms like leg swelling or pain.
Hershey, PennsylvaniaAges 18 years+ - NCT07402655Recruiting
Study on nerve injuries in the arm and their long-term effects
This study looks at people who have had a recent nerve injury in their arm, hand, or wrist that needed treatment. It aims to understand how the injury affects movement, feeling, and quality of life over time.
IspartaAges 18–80
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,242 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.